Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2025-12-25 @ 11:58 AM
NCT ID:
NCT02971761
Group ID:
EG000
Title:
Treatment (Pembrolizumab, Enobosarm)
Description:
Patients receive pembrolizumab IV over 30 minutes on day 1 and enobosarm PO QD on days 1-21. Courses repeat every 21 days for up to 35 cycles in the absence of disease progression or unacceptable toxicity.
Enobosarm: Given PO
Laboratory Biomarker Analysis: Correlative studies
Pembrolizumab: Given IV
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
18
Other Number Affected:
18
Other Number At Risk:
18
Study:
NCT02971761
Results Section:
NCT02971761
Adverse Events Module:
NCT02971761